Publikationen
Reinforced Biologic Mesh Reduces Postoperative Complications Compared to Biologic Mesh after
Ventral Hernia Repair
Ventral hernias represent a common complication of abdominal wall surgery and have an incidence of approximately 11%–20%.1 The prevalence of ventral hernia repairs (VHRs) continues to rise steadily, with more than 400,000 surgeries performed each year in the United States.2 Direct surgical repair can have a failure rate of up to 50%, but the introduction of prosthetic materials in the form of nonabsorbable synthetic meshes has led to a significant reduction in hernia recurrence rates.
Reinforced Biologic reduces risk of recurrence in ventral hernia (VH) patients: 1-year data from the BRAVO Ventral Hernia Study
George DeNoto III, MD, FACS, on behalf of the BRAVO study group* Director of General Surgery at St. Francis Hospital NY
To report the one year results in the first 32 patients enrolled in the BRAVO clinical trial (“Bioscaffold Reconstruction of Abdominal wall and Ventral hernia defects with Open or laparoscopic repair”). This prospective single-arm study evaluates the clinical performance of a Reinforced Biologic (RB) to reinforce repairs in 100 patients with a variety of ventral hernias.
24-Month results of the BRAVO study Annals of Medicine and Surgery 83 (2022)
A prospective, multi-center study evaluating the clinical outcomes of a ventral hernia cohort treated with OviTex® 1S permanent reinforced tissue matrix.
New Ovine Polymer-Reinforced Bioscaffold
in Hiatal Hernia Repair
Michael A. J. Sawyer, MD
Background and Objectives: Biologic and resorbable synthetic materials are used commonly for crural repair reinforcement during laparoscopic hiatal herniorrhaphy. Recently, an ovine polymer-reinforced bioscaffold (OPRBS) has been developed for reinforcement of abdominal wall and hiatal herniorrhaphies. This is the first reported series on use of OPRBS in hiatal hernia repairs.
Use of Ovine Reinforced Tissue Matrix in Bridged Incisional Hernia Repair
George DeNoto III, MD, FACS, Director of General Surgery at St. Francis Hospital NY
Twenty-two patients with high incidence of comorbidities and history of prior ventral hernia recurrences were repaired with OviTex RTM. Human and Porcine acellular dermal matrices have been shown to have recurrence rates in bridged patients of 80% and 40% respectively. The recurrence rate of 14% in our experience, at our practice, using ovine RTM in bridged repairs of ventral hernias appears to be an improvement.
Semiresorbable biologic hybrid meshes for ventral abdominal hernia repair in contaminated settings
Markus Goetz · Maria Jurczyk · Henrik Junger · Hans J. Schlitt · Stefan M. Brunner · Frank W. Brennfleck
In case of potential contamination, implantation of synthetic meshes in hernia and abdominal wall surgery is problematic due to a higher risk of mesh infection. As an alternative, a variety of different biologic meshes have been used.
Biological abdominal wall expansion in pediatric liver recipients after transplantation with large-for-size organs
After pediatric split liver transplantation, intra-abdominal loss of domain due to large-for-size left lateral grafts is a frequent problem for fascial closure and potentially leads to reduced liver perfusion and abdominal compartment syndrome. Therefore, delayed fascial closure with the use of temporary silastic meshes and reoperation or alternative fascial bridging procedures are necessary.
Clinical outcomes of open abdominal wall reconstruction with the use of a polypropylene reinforced tissue matrix: a multicenter retrospective study
Objective To assess mesh behaviour and clinical outcomes of open complex abdominal wall reconstruction (CAWR) with the use of a polypropylene reinforced tissue matrix.